Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Naprosyn
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Naprosyn 500mg tablets
1001010P0BCABAE
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 395 |
|
Naprosyn EC 500mg tablets
1001010P0BCAIAI
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 299 |
|
Naprosyn 250mg tablets
1001010P0BCAAAD
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 280 |
|
Naprosyn EC 250mg tablets
1001010P0BCAGAH
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 254 |
|
Naprosyn EC 375mg tablets
1001010P0BCAHAJ
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | 146 |
|
Naprosyn 125mg/5ml oral suspension
1001010P0BCACAR
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naprosyn 500mg suppositories
1001010P0BCADBG
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naprosyn Pain Relief 250mg gastro-resistant tablets
1001010P0BCAKAH
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naprosyn S/R 500mg tablets
1001010P0BCAJAQ
|
Naprosyn | Naproxen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.